Peptide Protocols

Most peptide brands will ship you a product and move on. You're on your own to figure out: - Dosing - Titration schedule - Side effects - Whether what you're doing is actually working For something you're injecting into your body, that's a serious gap. I spent years learning this through a high-end regenerative medicine doctor that most people don't have access to. Most people hear about something on social media, find a brand online, order it, and hope for the best. The peptide space has genuinely powerful compounds in it. But the distance between "this product works" and "this product is working for you, correctly and safely" is enormous. Closing that gap is the entire point of why we built Kora MD®. Every membership includes the medication (same price at any dose), the protocol, and a licensed clinician from day one.

In 8 days the FDA decides the fate of the peptides half of biohacking Twitter is already taking. On July 23–24 it reviews seven of them: In 8 days the FDA decides the fate of the peptides half of biohacking Twitter is already taking. On July 23–24 it reviews seven of them: BPC-157, TB-500, MOTS-c, KPV, Semax, Epitalon, emideltide. The question on the table: can compounding pharmacies keep selling them at all. Four are already being pushed as Long COVID fixes BPC-157, TB-500, MOTS-c and KPV, promising less inflammation, more energy, tissue repair, sharper focus. There's limited to no human data behind any of it. Scripps cardiologist Eric Topol didn't hedge: "I don't think it's wise for people with Long COVID, or anyone for that matter, to take the risk of trying unapproved peptides." Note the word: unapproved. Because some peptides do have real Long COVID trials behind them the GLP-1s, Semaglutide and tirzepatide, same class as Ozempic and Mounjaro. . Scripps is running a tirzepatide trial, data due late this year. The NIH is about to start one on semaglutide. And an April survey of 120 people with Long COVID or ME/CFS found 53% improved on a GLP-1, 28% got worse. Demand is years ahead of the science, and the marketing won't tell you that. We'll be watching the vote on the 23rd. Follow along if you'd rather hear it from us than from the people selling the product.

"Just shake it and leave it on the shelf, bro." No. MYTH: Shaking mixes it better → Truth: it foams and degrades the peptide. Swirl. MYTH: Room temp is fine → Truth: reconstituted = fridge, or it dies in days. MYTH: Re-using pins is fine → Truth: dull needle, scar tissue, contamination. Technique is the difference between results, hospital visit and wasted money.

So after using Retatrutide for several months, my LDL-c (30mg/dL) is so low that my insurance won't cover my Repatha script anymore. I guess I probably don't actually need to be on Repatha anymore, anyway.